首页/数据集/Barriers and facilitators to the success of the LATCH feasibility trial (2014–2016).

Barriers and facilitators to the success of the LATCH feasibility trial (2014–2016).

Figshare2025-01-09 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Barriers_and_facilitators_to_the_success_of_the_LATCH_feasibility_trial_2014_2016_/28176351 数据链接链接失效反馈

官方服务：

资源简介：

Barriers and facilitators to the success of the LATCH feasibility trial (2014–2016).

应用场景：

创建时间：

2025-01-09

发育毒性评估

临床试验安全性评估

The test substance is administered in graduated doses to several groups of males and females. Males should be dosed for a minimum of four weeks. Females should be dosed throughout the study, so approx

Organisation for Economic Co-operation and Development30

Frequency of AEs and maximum AE grade/subject after treatment by type of treatment and gender, October 2016−February 2017.

药物不良事件

临床试验安全性评估

Frequency of AEs and maximum AE grade/subject after treatment by type of treatment and gender, October 2016−February 2017.

NIAID Data Ecosystem20

Number of subjects presenting possible or probable related adverse events.

药物不良反应监测

临床试验安全性评估

Number of subjects presenting possible or probable related adverse events.

Figshare2017-02-10 更新10

Trial of TG4023 Combined With Flucytosine in Liver Tumors

肝肿瘤基因治疗

临床试验安全性评估

This trial is a phase I, open-label, dose-escalating study of the safety or percutaneous intra-tumoral injection of TG4023 (MVA-FCU1) combined with systemic administration of 5-fluorocytosine in patie

NIAID Data Ecosystem30

ATN 109 Adverse Event Explanation Form: Signs and Symptoms [CRF 95] Dataset in Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir

HIV药物副作用

临床试验安全性评估

Data from Adverse Event Explanation Form: Signs and Symptoms [CRF 95] Study Description A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus placebo every 4 weeks

NIAID Data Ecosystem10

Barriers and facilitators to the success of the LATCH feasibility trial (2014–2016).

资源简介：

相关数据集